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a  b  s  t  r  a  c  t
Diabetes  mellitus  (DM)  during  pregnancy  causes  congenital  malformation,  macrosomia,  respiratory  dis-
tress syndrome,  and  other abnormalities  in  neonates,  but  whether  maternal  DM  affects  the neonatal
innate  immune  system  is  unknown.  Therefore  we  aimed  to reveal  the  inﬂuence  of DM in pregnancy  on
the  toll-like  receptor  (TLR)–mediated  innate  immune  response  in neonates.  Cord  blood  was  collected
after  full-term  vaginal  or cesarean  delivery  and  classiﬁed  into  a DM  group (n  = 8)  and  non-DM  (control)
group  (n =  7). Mononuclear  cells  were  harvested  from  cord  blood  by using  density  gradient  centrifugation,
after  which  anti-CD14  magnetic  beads  were  used  to isolate  monocytes  from  the mononuclear  population.
After  monocytes  were  cultured  with  lipopolysaccharide  (TLR4  ligand),  ﬂagellin  (TLR5  ligand),  Pam3CSK4
(TLR1/TLR2  ligand),  zymosan  (TLR2/TLR6  ligand),  or  macrophage-activating  lipopeptide  (TLR2/TLR6  lig-
and)  for  12  h, the  cytokine  levels  (interleukin  [IL]-8,  IL-6,  IL-1,  IL-10,  tumor  necrosis  factor  alpha  and
IL-12)  in  the  culture  supernatants  were  measured.  Compared  with  the  control  group,  the DM  group  had
higher  concentrations  of IL-8  (P = 0.01)  and  tumor  necrosis  factor  alpha  (P =  0.02)  after  monocyte  cultures
were  stimulated  with  Pam3CSK4  and  higher  concentrations  of  IL-8  (P = 0.01)  after  ﬂagellin  treatment.  In
contrast,  stimulation  with  lipopolysaccharide,  zymosan,  or  macrophage-activating  lipopeptide  did  not
lead to  any  difference  in  cytokine  proﬁles  between  the  two  groups.  These  data  indicate  that  maternal  DM
induces  excessive  inﬂammatory  activation  in neonates  via a  TLR5-  or TLR1/2-mediated  innate  immune
response.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Maternal diabetes during pregnancy is well known to cause
erinatal morbidity and mortality in offspring (Wendland et al.,
012; Mitanchez et al., 2014; Gabbe and Graves, 2003). Poorly con-
rolled diabetes during the early weeks of gestation increases the
ates of spontaneous abortion and major congenital malformations,
ncluding atrial septal defect, anencephaly, sacral agenesis, and
enal agenesis (Gabbe and Graves, 2003). In the second trimester,
aternal hyperglycemia causes fetal hyperinsulinemia and fetal
Abbreviations: BMI, body mass index; DM,  diabetes mellitus; E. coli, Escherichia
oli;  GBS, group B streptococcus; GDM, gestational diabetes mellitus; HbA1c,
emoglobin A1c; IL, interleukin; LPS, lipopolysaccharide; L. monocytogenes, Listeria
onocytogenes;  MALP, macrophage-activating lipopeptide; NGSP, National Glyco-
emoglobin Standardization Program; TLR, toll-like receptor; TNF, tumor necrosis
actor.
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overgrowth, leading to a high risk of intrauterine fetal death during
the last 4–6 weeks of gestation (Gabbe and Graves, 2003). Further-
more, fetal hyperinsulinemia increases the incidence of respiratory
distress syndrome after birth (Gabbe and Graves, 2003).
Recent reports indicate that gestational diabetes mellitus (GDM)
can alter the placental and neonatal immune systems (Mrizak et al.,
2014; Atègbo et al., 2006). In one study, GDM was associated with
increased expression of interleukin (IL)-6, toll-like receptor (TLR) 4,
and transforming growth factor beta mRNA in the placenta (Mrizak
et al., 2014). Another study showed elevated levels of T helper type
1 cytokines and low levels of IL-10 in the serum of macrosomic
babies born to GDM mothers (Atègbo et al., 2006). However because
of the paucity of studies that focus on the interactions between the
immune system and DM in pregnancy, whether and how maternal
DM affects the neonatal immune system remain unclear.Due to the lack of pre-existing immunological memory in the
neonatal immune system, innate immunity and maternally trans-
ferred IgG play central roles in the protection against infection
(Maródi, 2006; Levy, 2007; Iwasaki and Medzhitov, 2004). Because
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eonates are more susceptible to infections and tend to experi-
nce more severe outcomes than do older children and adults
Lozano et al., 2012; Prendergast et al., 2012), understanding the
actors that affect the neonatal innate immune system is impor-
ant for developing protective strategies. In this regard, previous
eports have demonstrated that maternal alcohol intake and vita-
in  D deﬁciency signiﬁcantly exacerbate neonatal and infantile
nfections, thus suggesting the impairment of neonatal immunity
Gauthier et al., 2005; Belderbos et al., 2011). Another study dis-
losed the association of maternal smoking with impairment of
he TLR-mediated innate immune response in neonates (Noakes
t al., 2006). For these reasons, elucidating the maternal factors
hat inﬂuence neonatal innate immunity is paramount.
To date, studies demonstrating whether maternal diabetes
ffects the neonatal innate immune system are unavailable. There-
ore our current study aimed to evaluate the inﬂuence of maternal
iabetes during pregnancy on neonatal innate immunity by focus-
ng on the TLR complex. The TLR plays a key role in the innate
mmune system by recognizing pathogen-associated molecular
atterns on immune cells (Iwasaki and Medzhitov, 2004; Cuenca
t al., 2013; Akira and Takeda, 2004).
. Materials and methods
.1. Blood
Heparinized cord blood (30–50 ml)  was collected from the pla-
ental end of the transected umbilical cord immediately after
ull-term vaginal or cesarean delivery associated with DM in preg-
ancy; samples subsequently were allocated into a DM group
r a control group without DM and premature rupture of mem-
rane. The DM group comprised samples from subjects with type II
M, GDM, or overt DM (International Association of Diabetes and
regnancy Study Groups Consensus Panel, 2010).
GDM was diagnosed by using the 75-g oral glucose tolerance
est, as proposed by the International Association of Diabetes and
regnancy Study Groups (International Association of Diabetes and
regnancy Study Groups Consensus Panel, 2010). Brieﬂy, glucose
olerance was tested after a 12-h overnight fast. Venous blood
amples for the measurement of plasma glucose level and insulin
oncentration were drawn during the fasting state and at 30 min,
 h, and 2 h after ingestion of the glucose drink. GDM was  diagnosed
hen one or more values reached or exceeded the following thresh-
lds: fasting, 92 mg/dl; 1 h, 180 mg/dl; and 2 h, 153 mg/dl. Overt
M was diagnosed when one or more values reached or exceeded
he following thresholds: casual blood glucose, 200 mg/dl; fast-
ng blood glucose, 126 mg/dl; and hemoglobin A1c (HbA1c) which
s estimated as a National Glycohemoglobin Standardization Pro-
ram (NGSP) equivalent value, 6.5% (International Association of
iabetes and Pregnancy Study Groups Consensus Panel, 2010).
The study protocol conformed to the principles of the Declara-
ion of Helsinki. The ethics committee of our institution approved
he study protocol, and written informed consent was obtained
rom all subjects before the procedures were started.
.2. Proﬁles of mothers and neonates
The following data were collected regarding mothers: age at
elivery, body mass index (BMI), gestational weeks at delivery,
ode of delivery, blood glucose level, HbA1c (NGSP) percentage,
nd any treatment for DM.  BMI  was measured at the ﬁrst trimester.
lood glucose and HbA1c levels were measured at the ﬁrst trimester
r when GDM was diagnosed. The following data were collected
egarding neonates: birth weight, Apgar score, and IgM and insulin
oncentrations in the cord blood. The Apgar score was evaluated as Immunology 117 (2016) 17–23
previously described (Apgar, 1953); a score of 7–10 was  considered
normal.
2.3. Monocytes
Heparinized cord blood or adult peripheral blood were lay-
ered onto Lymphocyte Separation Medium (catalog no. 126-04871,
Wako Pure Chemical Industries Ltd., Osaka, Japan), and the
mononuclear cell layer was collected after centrifugation (Nohmi
et al., 2015). Monocytes were isolated from the mononuclear cells
by positive selection using magnetic microbeads coupled to an
anti-CD14 monoclonal antibody (catalog no. 130-050-201, Mil-
tenyi Biotec, Auburn, CA, USA) as previously described (Nohmi
et al., 2015). Approximately 1 × 107 CD14-positive monocytes were
harvested from 50 ml  of cord blood. Cord blood monocytes were
transferred to 96-well plates (105 cells/well) and left untreated
(controls) or incubated with lipopolysaccharide (LPS; TLR4 ligand;
10, 100, and 1000 ng/ml; Escherichia coli serotype O111 B4, Sigma,
St. Louis, MO,  USA), ﬂagellin (TLR5 ligand; 1, 10, and 100 ng/ml; cat-
alog no. IMG-2205, Imgenex, San Diego, CA, USA), zymosan (TLR2
and TLR6 heterodimer ligand; 0.1, 1, and 10 g/ml; catalog no.
IMG-2212, Imgenex), Pam3CSK4 (TLR1 and TLR2 heterodimer lig-
and; 10, 100, and 1000 ng/ml; catalog no. IMG-2201, Imgenex),
and macrophage-activating lipopeptide (MALP; TLR2 and TLR6 het-
erodimer ligand; 10, 100, and 1000 ng/ml; catalog no. IMG-2206,
Imgenex) for 12 h at 37 ◦C in humidiﬁed air containing 5% CO2.
2.4. Cytokine assay
The concentrations of human IL-8, IL-1, IL-6, IL-10, tumor
necrosis factor (TNF)-,  and IL-12p70 in the cell-culture super-
natants were measured by using a human inﬂammatory cytokine
cytometric bead assay kit (catalog no. 551811, BD Pharmingen, San
Jose, CA, USA) in accordance with the manufacturer’s instructions.
Brieﬂy, 50 l of supernatant was  mixed with 50 l of mixed capture
beads. After 3 h of incubation at room temperature, the samples
were washed, suspended in phosphate-buffered saline, and then
analyzed by ﬂow cytometry (FACS LSR II, Becton Dickinson, Franklin
Lakes, NJ, USA) with the CBA Analysis Software (BD Biosciences).
2.5. Statistical analysis
The cytokine concentrations stimulated by the TLRs and the pro-
ﬁles of the mothers and neonates were compared between the DM
group and the control group by using the Mann–Whitney U test.
P < 0.05 was  considered statistically signiﬁcant. The statistical soft-
ware package SPSS Statistics 21 (IBM, Armonk, NY, USA) was  used
for all data analyses.
3. Results
3.1. Characteristics of mothers and neonates
Table 1 summarizes the characteristics of the mothers. The
DM group comprised 5 cases of GDM, 2 of overt DM,  and 1
of type 2 DM.  Only one mother had been treated by diet only,
whereas the remaining 7 women received insulin. Mothers’ age,
gestational weeks at delivery, and mode of delivery did not dif-
fer between groups; BMI  was  higher in the DM group than in
the control group (P < 0.01). The casual blood glucose and HbA1c
(NGSP) levels (mean ± 1SD) of the DM group were 126 ± 42 mg/dl
and 6.1% ± 1.1%, respectively, and did not differ from those in the
control group.
As shown in Table 2, Apgar scores and birth weight were similar
between the DM and control groups. The insulin concentration and
glucose of cord blood were 5.47 ± 3.56 IU/ml and 66 ± 22 mg/dl
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Fig. 1. Cytokine proﬁles after LPS stimulation.
Cytokine proﬁles (IL-8, IL-1, IL-6, IL-10, TNF-, and IL-12p70) after LPS stimulation did not differ between the DM and control groups.














cig. 2. Cytokine proﬁles after zymosan stimulation.
ytokine proﬁles (IL-8, IL-1, IL-6, IL-10, TNF-, and IL-12p70) after zymosan stimu
L,  interleukin; TNF-, tumor necrosis factor-; DM,  diabetes mellitus.
n the DM group and 2.44 ± 0.90 IU/ml and 68 ± 29 mg/dl in the
ontrol group; these values did not differ signiﬁcantly. There were
o signiﬁcant differences in umbilical artery pH and PO2/PCO2
etween these groups. None of the newborns in either group had
acrosomia, cardiac anomaly, respiratory distress syndrome, or
nfectious diseases.
.2. Stimulation by TLR ligands
The amount of IL-8, IL-1, IL-6, IL-10, TNF-, and IL-12p70 pro-
uced did not differ between the DM and control groups when
onocyte cultures were stimulated by using LPS, zymosan, or MALP
t any of the concentrations tested (Figs. 1–3 ).
However, when stimulated by using Pam3CSK4 at 10 ng/ml,
oncentrations of IL-8 (P = 0.01) and TNF- (P = 0.02) were higher did not differ between the DM and control groups.
in the DM group than the control group. In comparison, IL-1,
IL-6, IL-10, and IL-12p70 levels did not differ between groups at
any Pam3CSK4 concentration tested; and IL-8 and TNF- levels
in both groups were similar when Pam3CSK4 was  used at 100 or
1000 ng/ml (Fig. 4). Stimulation of monocyte cultures with ﬂagellin
led to differences in IL-8 concentration between the two  groups
only at 100 ng/ml (P = 0.01), and none of the other cytokines differed
at any of the ﬂagellin levels tested (Fig. 5).
4. DiscussionInnate immunity is the critical ﬁrst-line defense against the
invasion of infectious pathogens in neonates (Maródi, 2006; Levy,
2007; Cuenca et al., 2013). In the present study, we  have demon-
strated that the innate immune response of cord blood monocytes
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Fig. 3. Cytokine proﬁles after MALP stimulation.
Cytokine proﬁles (IL-8, IL-1, IL-6, IL-10, TNF- and IL-12p70) after MALP stimulation did not differ between the DM and control groups.
IL,  interleukin; TNF-, tumor necrosis factor-; MALP, macrophage-activating lipopeptide; DM,  diabetes mellitus.

















sfter simulation with Pam3CSK4 at 10 ng/ml, concentrations of IL-8 (P = 0.01) and TN
roﬁles (IL-8, IL-1, IL-6, IL-10, TNF-, and IL-12p70) did not differ between groups
L,  interleukin; TNF-, tumor necrosis factor-; DM,  diabetes mellitus.
which represents that of neonates) differs between diabetic
nd non-diabetic mothers. Speciﬁcally, stimulation of TLR4, TLR5,
LR1/TLR2 heterodimer, and TLR2/TLR6 heterodimer revealed that
he TLR5- and TLR1/2-mediated neonatal inﬂammatory immune
esponses were elevated during diabetes-associated compared
ith non-diabetic pregnancy. To our knowledge, this study is the
rst to compare the innate immune response of cord blood immune
ells reﬂecting neonatal innate immunity between diabetic and
on-diabetic mothers.
TLR-mediated signaling has both beneﬁcial and harmful effects
n terms of pathogen invasion (Iwasaki and Medzhitov, 2004, 2015;
kira and Takeda, 2004; Nakanaga et al., 2007; Kollmann et al.,
012; Subramanian et al., 2008; Liaudet et al., 2003; Wright and
irpalani, 2011; Ghezzi et al., 1998). As a beneﬁcial effect, TLR
ignaling induces potent innate immune responses for the initialP = 0.02) were signiﬁcantly higher in the DM group than the control group. Cytokine
 stimulation with Pam3CSK4 at concentrations of 100 ng/ml or 1000 ng/ml.
host defense against pathogenic bacteria; this initial response leads
to acquired immunity (Iwasaki and Medzhitov, 2004; Akira and
Takeda, 2004). Dendritic cells recognize pathogens via pathogen-
recognition receptors (such as TLRs), secrete cytokines (IL-6, IL-1,
IL-12, etc.), and stimulate lymphocyte differentiation pathways
(Iwasaki and Medzhitov, 2004). Another study showed that IL-8,
a neutrophil chemoattractant, and TNF- contribute to the airway
defense against airborne bacteria (Nakanaga et al., 2007).
In contrast to its beneﬁcial outcomes, TLR signaling causes a
harmful effect by producing proinﬂammatory cytokines, which
lead to exacerbation of inﬂammation in immune diseases or multi-
ple organ injury during sepsis (Kollmann et al., 2012; Subramanian
et al., 2008; Liaudet et al., 2003; Wright and Kirpalani, 2011). A
previous study indicated that IL-8 release from colonic epithelial
cells during the TLR5-mediated response to mucosal Escherichia
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Fig. 5. Cytokine proﬁles after ﬂagellin stimulation.
After stimulation with ﬂagellin at 100 ng/ml, concentrations of IL-8 were signiﬁcantly hig
IL-6,  IL-10, TNF-, and IL-12p70) did not differ between the DM and control groups after 
IL,  interleukin; TNF-, tumor necrosis factor-; DM,  diabetes mellitus.
Table 1






Age (years) 35 ± 5 33 ± 6 NS
BMI  26 ± 3 19 ± 1 <0.001
Duration of pregnancy (weeks) 38 ± 2 38 ± 2 NS
Mode of delivery CS = 3 CS = 4 NS
VD = 4 VD = 4
Blood glucose (mg/dl) 126 ± 42 112 ± 32 NS
HbA1c (NGSP) (%) 6.1 ± 1.1 5.4 ± 0.2 NS
DM  treatment Insulin = 7 Not applicable
Diet = 1
DM,  diabetes mellitus; BMI, body mass index; HbA1c, hemoglobin A1c; CS, cesarean
section; VD, vaginal delivery; NS,  not signiﬁcant.
Data are given as mean ± 1SD, where appropriate.
a The DM group comprised 5 mothers with GDM, 2 with overt DM,  and 1 with
type 2 DM.
b The Mann–Whitney U test was used to compare the two  groups.
Table 2






Birth weight (g) 2993 ± 572 3194 ± 339 NS
Apgar score (5 min) 9 ± 0.5 9 ± 0.4 NS
Umbilical artery pH 7.320 ± 0.02 7.317 ± 0.05 NS
Umbilical artery PO2 (mmHg) 19.1 ± 5.7 23.9 ± 11.0 NS
Umbilical artery PCO2 (mmHg) 45.7 ± 2.9 42.1 ± 6.5 NS
Umbilical glucose (mg/dl) 66 ± 22 68 ± 29 NS
Umbilical IgM (mg/dl) 8.1 ± 1.8 9.3 ± 1.8 NS
Umbilical insulin (IU/ml) 5.47 ± 3.56 2.44 ± 0.90 NS








ellin, making it rational to consider that TLR5 does not inﬂuence GBSata are given as mean ± 1SD.
a The Mann–Whitney U test was used to compare the two  groups.
oli contributes to the severity of inﬂammatory bowel disease
Subramanian et al., 2008). In another study, TLR5-mediated IL-8
roduction was revealed to induce acute respiratory inﬂamma-
ion in gram-negative bacterial sepsis (Liaudet et al., 2003). In
egard to neonatal disease, TLR-mediated inﬂammation is involved
n the development of bronchopulmonary dysplasia (Wright andher (P = 0.01) in the DM group than the control group. Cytokine proﬁles (IL-8, IL-1,
stimulation with ﬂagellin at concentrations of 1 or 10 ng/ml.
Kirpalani, 2011), and elevated IL-8 concentrations in amniotic ﬂuid
and neonatal plasma are known as a predisposing factor for bron-
chopulmonary dysplasia (Wright and Kirpalani, 2011; Ghezzi et al.,
1998). In our current study, ﬂagellin, a TLR5 ligand, led to excessive
IL-8 production in the children of diabetic mothers. In addition,
Pam3CSK4, a TLR1/2 ligand, induced the excess production of IL-8
and TNF- in these same neonates. Taken together with previ-
ous studies, our current results indicate that the hyperresponsive
innate immune system in the offspring of diabetic mothers con-
tributes to the development of organ injury during infection.
In neonates, group B streptococcus (GBS) and E. coli are the
most important pathogens in the early-onset neonatal infection
causing sepsis and meningitis (Stoll et al., 2011), and Listeria mono-
cytogenes (L. monocytogenes) follows GBS and E. coli in clinical
signiﬁcance (Simonsen et al., 2014). Regarding the role of TLRs
in infection with these pathogens, TLR5 and TLR1/2 are closely
involved in the immune response to E. coli and L. monocytogenes
(Hayashi et al., 2001; Khan et al., 2004; Andersen-Nissen et al.,
2007; Remuzgo-Martínez et al., 2013). In addition, TLR5 recog-
nizes L. monocytogenes through its ﬂagellin (Hayashi et al., 2001),
and TLR5 is necessary for E. coli-mediated IL-8 secretion (Khan
et al., 2004), whereas TLR5 deﬁciency increases the susceptibility
of mice to E. coli-induced urinary tract infections (Andersen-Nissen
et al., 2007). As for L. monocytogenes, TLR2 participates in the devel-
opment of protective immunity against L. monocytogenes (Torres
et al., 2004), and lipoproteins of L. monocytogenes activate the
TLR2-mediated innate immune response (Machata et al., 2008).
Furthermore, TLR2 is believed to require TLR1 or TLR6 for the induc-
tion of the innate immune response. In this regard, because TLR1
and TLR2 gene expression is increased during L. monocytogenes
infection (Remuzgo-Martínez et al., 2013), TLR1/2-mediated innate
immunity is considered to be critically involved in this process.
Although several studies have demonstrated the role of TLR2 in GBS
infection (Draper et al., 2006; Henneke et al., 2008), because lipote-
ichoic acid from GBS interacts with TLR2/6 (Henneke et al., 2005),
TLR1 may  not interact with GBS. In addition, GBS don’t have ﬂag-infection. Given the described ﬁndings indicating the interaction of
TLR5 or TLR1/2 and E. coli or L. monocytogenes, our current results
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f IL-8 or TNF- (or both) in the neonates of diabetic mothers may
ontribute to the deleterious outcome after early neonatal infection
ith E. coli or L. monocytogenes.
Because maternal DM in our study was well controlled during
regnancy, the neonates were free of typical major DM-associated
omplications, such as macrosomia and respiratory distress syn-
rome. However, despite effective disease control, maternal DM led
o excessive innate immune responses in the offspring. Although
n increased risk of organ injury after infection in neonates born
o mothers with DM/GDM has not yet been reported, our study
ndicates that maternal diabetes, like smoking and alcohol intake,
hould be acknowledged as an important factor in worsening out-
omes after neonatal infection (Gauthier et al., 2005; Belderbos
t al., 2011; Noakes et al., 2006). Perhaps because macrosomia,
ongenital malformations, hypoglycemia, and respiratory distress
yndrome are well-known neonatal complications of maternal DM,
he effects of maternal DM on neonatal immunity may  not have
arnered appropriate attention to date. However, recent ﬁndings
ndicate that GDM can alter the placental and neonatal immune sys-
ems (Mrizak et al., 2014; Atègbo et al., 2006), and our present study
evealed that maternal DM ‘hyperactivates’ the neonatal innate
mmune response. A future clinical study likely will prove help-
ul in disclosing the relation between maternal DM and neonatal
utcome after infection.
Another important aspect of our study is maternal obesity and
ts possible involvement in neonatal innate immunity. Compared
ith the control group, the mothers comprising the DM group had
 signiﬁcantly increased BMI, with a mean value of 26, indicating
besity. A recent study demonstrated that, compared with their
on-obese counterparts, the pups of a rat obesity model (fed a
estern diet) experienced worse outcomes after bacterial infection
nd experimentally induced autoimmunity—reactions indicative of
 hyperactive innate immune response (Wilson and Messaoudi,
015). In another animal experiment, maternal obesity primes
he offspring for nonalcoholic fatty liver disease through innate
mmune dysfunction associated with elevated hepatic expression
f IL-6, TNF-, and transforming growth factor (Mouralidarane
t al., 2013). Together this evidence implies that maternal obesity
ontributes to the activation of neonatal innate immunity. How-
ver, it is a commonly held belief that the risk of DM/GDM is
ositively associated with obesity (Torloni et al., 2009). Separating
he inﬂuence of maternal DM on the offspring from that of maternal
besity is difﬁcult.
In conclusion, we have demonstrated that maternal DM asso-
iated with obesity induced excessive IL-8 and TNF- release in
eonates via a TLR5- or TLR1/2-mediated innate immune response.
his scenario may  be relevant to the systemic inﬂammation due to
arly-onset neonatal infection.
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